Gene Therapy for Neurological Disorders
Evvnt Promotion / evvnt
06.12.2021 - 09.12.2021 The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:30 am - 5:30 pm
Conference themes
Returning to Boston this December, the 3rd Gene Therapy for Neurological Disorders meeting will welcome discovery, preclinical, translational and clinical industry scientists to share, learn and network for the shared goal of successfully and safely delivering gene therapies to the CNS.
Returning to Boston this December, the 3rd Gene Therapy for Neurological Disorders meeting will welcome discovery, preclinical, translational and clinical industry scientists to share, learn and network for the shared goal of successfully and safely delivering gene therapies to the CNS.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/853497-0?pid=4832
Speakers: Alan Foster, Chief Scientific Officer, Otonomy, Inc., Alexandra Watt, Lead Research Analyst, Beacon Targeted Therapies and more
Brochure: https://go.evvnt.com/853497-0?pid=4832
Speakers: Alan Foster, Chief Scientific Officer, Otonomy, Inc., Alexandra Watt, Lead Research Analyst, Beacon Targeted Therapies and more
Enquiries and Registration:
https://go.evvnt.com/853497-1?pid=4832
Ms. Ellie Saunders
Clinical Research, General Medicine
Languages
English
English
Congress fees
Full Access Pass - Physical - Standard Rate: USD 3593.00, Conference + Workshop Day OR Post Event Delivery Day - Physical - Standard Rate: USD 2846.00, Conference Only - Physical - Standard Rate: USD 2099.00
Full Access Pass - Physical - Standard Rate: USD 3593.00, Conference + Workshop Day OR Post Event Delivery Day - Physical - Standard Rate: USD 2846.00, Conference Only - Physical - Standard Rate: USD 2099.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
